Advocacy intelligence hub — real-time data for patient organizations
Case Comprehensive Cancer Center — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
WEGOVY
(SEMAGLUTIDE)acceleratedNovo Nordisk
GLP-1 Receptor Agonist [EPC]
12.1 Mechanism of Action Semaglutide is a GLP-1 analogue with 94% sequence homology to human GLP-1. Semaglutide acts as a GLP-1 receptor agonist that ...
Browse all STING-associated vasculopathy with onset in infancy news →
View all STING-associated vasculopathy with onset in infancy specialists →